molmir, Inc. has been selected as a startup for the Nakanoshima Qross Drug Discovery and Practical Application Promotion Program Support Project, which was adopted by the Ministry of Health, Labor and Welfare’s Drug Discovery Cluster Campus Development Project, implemented by the Japan Agency for Medical Research and Development (AMED) and the Future Medical Promotion Organization (Nakanoshima Qross).
We are honored to participate in this support program aimed at advancing the practical application and global expansion of drug discovery seeds, and we are pleased to share this milestone with you.
Additionally, we will be presenting at the kickoff event held on the afternoon of Thursday, August 21, at Nakanoshima Qross. The event will feature pitches from the selected startups, panel discussions with pharmaceutical companies and investors, and networking opportunities. We warmly invite you to attend and hope it will serve as a valuable occasion for future collaboration and information exchange.
───────────────
Event Title: Nakanoshima Qross Drug Discovery Cluster Campus Project Kickoff Event
Date & Time: Thursday, August 21, 2025, 13:30–18:30
Venue: Nakanoshima Qross 1F, Congress Square Osaka Nakanoshima (Square323)
4-3-51 Nakanoshima, Kita-ku, Osaka City
Hybrid format: On-site (Osaka, Nakanoshima) and Online
Capacity: 200 on-site / 300 online
Admission: Free
Registration: https://nq20250821.peatix.com
───────────────
We sincerely appreciate your continued support.
